EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Variants in BIRC5 (rs8073069, rs17878467, and rs9904341) Are Associated with Susceptibility in Mexican Patients with Breast Cancer: Clinical Associations and Their Analysis In Silico

María Renee Jiménez-López, César de Jesús Tovar-Jácome iD, Alejandra Palacios-Ramírez iD, Martha Patricia Gallegos-Arreola iD, Teresa Giovanna María Aguilar-Macedo, Rubria Alicia González-Sánchez, Efraín Salas-González, José Elías García-Ortiz iD, Clara Ibet Juárez-Vázquez, Mónica Alejandra Rosales-Reynoso

Genes · 2025

DOI: 10.3390/genes16070786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von María Renee Jiménez-López und 9 weiteren Autor:innen. Beteiligte Einrichtung: División de Medicina Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Sierra Mojada 800…. Hauptthemen laut MEDLINE: Breast Neoplasms, Survivin, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Mexicano del Seguro Social (IMSS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Breast cancer (BC) is a multifactorial disease, with genetic alterations in cell proliferation and migration pathways being significant risk factors. This study examines the association between three variants in the BIRC5 gene (rs8073069, rs17878467, and rs9904341) and breast cancer (BC) susceptibility.

Methods

Peripheral blood DNA samples were collected from 423 women (221 BC patients and 202 healthy controls). Genotyping was performed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) methodology. Associations were calculated using odds ratios (OR), with p-values adjusted by the Bonferroni test (significance at p ≤ 0.016). In silico analyses were conducted to predict the functional impact of the analyzed variants.

Results

Patients carrying the C/C genotype for the rs8073069 variant showed increased susceptibility to BC with early TNM (tumor-node-metastasis classification) stage and Luminal A subtype (OR > 2.00; p ≤ 0.004). For the rs17878467 variant, patients with the C/T or T/T genotype exhibited a higher susceptibility to developing breast cancer (BC), particularly at early TNM stages or with a histological lobular type (OR > 2.00; p ≤ 0.012). Regarding the rs9904341 variant, patients with the G/C or C/C genotype had a higher susceptibility to breast cancer. Notably, G/C genotype carriers with Luminal A and B subtypes, and C/C genotype carriers who had TNM stages II and III, and Luminal A, Luminal B, and HER2 subtypes demonstrated increased risk (OR > 2.00; p ≤ 0.009). The C-T-C haplotype (rs8073069–rs17878467–rs9904341) was significantly associated with BC (OR = 4.20; 95% CI = 2.38–7.41; p ≤ 0.001). In silico analysis using CADD indicated a low probability of deleterious effects.

Conclusions

The results suggest that the rs8073069, rs17878467, and rs9904341 variants in BIRC5 have a significant influence on breast cancer susceptibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsSurvivinGenetic Predisposition to DiseasePolymorphism, Single NucleotideHumansFemaleMiddle AgedMexicoAdultCase-Control StudiesAgedComputer SimulationGenotypeHaplotypes

Stichwörter der Autor:innen

BIRC5breast cancergenotypeshaplotypessusceptibility

Substanzen

SurvivinBIRC5 protein, human

Autor:innen und Institutionen

  • División de Medicina Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Sierra Mojada 800, Col. Independencia, Guadalajara 44340, Mexico.
  • Servicio de Ginecología Oncológica, Unidad Médica de Alta Especialidad, Hospital de Ginecología y Obstetricia, Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44329,…
  • División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Sierra Mojada 800, Col. Independencia, Guadalajara 44340, Mexico.
  • Dirección Académica Aparatos y Sistemas I, Facultad de Medicina, Decanato Ciencias de la Salud, Universidad Autónoma de Guadalajara (UAG), Zapopan 45129, Mexico.
  • Servicio de Oncología Médica, Unidad Médica de Alta Especialidad, Hospital de Ginecología y Obstetricia, Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44329, Jalisc…

ORCID-Profile: César de Jesús Tovar-Jácome, Alejandra Palacios-Ramírez, Martha Patricia Gallegos-Arreola, José Elías García-Ortiz

Förderung

  • Instituto Mexicano del Seguro Social (IMSS)

Zitieren

APA

Jiménez-López, M. R., Tovar-Jácome, C. J., Palacios-Ramírez, A., Gallegos-Arreola, M. P., Aguilar-Macedo, T. G. M., González-Sánchez, R. A., Salas-González, E., García-Ortiz, J. E., Juárez-Vázquez, C. I., & Rosales-Reynoso, M. A. (2025). Genetic Variants in BIRC5 (rs8073069, rs17878467, and rs9904341) Are Associated with Susceptibility in Mexican Patients with Breast Cancer: Clinical Associations and Their Analysis In Silico. Genes. https://doi.org/10.3390/genes16070786

Vancouver

Jiménez-López MR, Tovar-Jácome CJ, Palacios-Ramírez A, Gallegos-Arreola MP, Aguilar-Macedo TGM, González-Sánchez RA, et al. Genetic Variants in BIRC5 (rs8073069, rs17878467, and rs9904341) Are Associated with Susceptibility in Mexican Patients with Breast Cancer: Clinical Associations and Their Analysis In Silico. Genes. 2025. doi:10.3390/genes16070786

BibTeX
@article{JimnezLpez2025,
  author = {Jiménez-López, María Renee and Tovar-Jácome, César de Jesús and Palacios-Ramírez, Alejandra and Gallegos-Arreola, Martha Patricia and Aguilar-Macedo, Teresa Giovanna María and González-Sánchez, Rubria Alicia and Salas-González, Efraín and García-Ortiz, José Elías and Juárez-Vázquez, Clara Ibet and Rosales-Reynoso, Mónica Alejandra},
  title = {Genetic Variants in BIRC5 (rs8073069, rs17878467, and rs9904341) Are Associated with Susceptibility in Mexican Patients with Breast Cancer: Clinical Associations and Their Analysis In Silico},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16070786}
}
Kostenlos starten →